Document:

<PAGE>

                                  EXHIBIT 10.20

                               NEWSEDGE AGREEMENT

                               DATED MAY 27, 2000

<PAGE>

May 25, 2000

Mr. Mark Ressa
Vice President Corporate Development
thehealthchannel.com
260 Newport Center Drive # 250
Newport Beach, CA 92660

Dear Mark,

Based on our discussions, NewsEdge is pleased to present thehealthchannel.com
with the following eTopics-TM- proposal for an Internet news solution. Outlined
below is a description of the service and pricing.

The proposal is based on the following assumptions:

1. NewsEdge will provide eTopics-TM- to thehealthchannel.com for use on a
   designated thehealthchannel.com site: http://www.thehealthchannel.com
2. thehealthchannel.com will purchase eTopics-TM- with unlimited end-user access
   to the designated site.
3. thehealthchannel.com has decided to host their service and will receive an
   SGML feed from NewsEdge. NewsEdge will FTP the SGML feed to a secure FTP
   site. thehealthchannel.com will be given an id/password to the FTP site
   allowing them to pull their SGML feed to their server. The FTP feed is
   delivered daily between 5am & 7am EST.

COMPANY OVERVIEW
NewsEdge Corporation is the world's largest independent news integrator and the
leader in global news and current awareness solutions for business. The
company's mission is to make news valuable for business. NewsEdge provides
clients at nearly 1,200 organizations with a powerful combination of customized,
authoritative content; cutting-edge technology; editorial, value-added
capabilities; and unparalleled client support and consulting services. NewsEdge
helps business people find the most important, relevant stories from an
overwhelming volume of daily news and enables them to act on the most current
information possible.

<PAGE>

PRODUCT OVERVIEW
eTopics-TM- is an automated means to updating your web page each business day
with the most current news that is uniquely relevant to your visitors. The
service takes advantage of NewsEdge's vast experience in news delivery and
NewsEdge's editorial expertise to completely news-enable your web site.

Simply select from the NewsEdge library of 1,300 industry-focused eTopics-TM-.
The selection should meet the needs and interest of your audience. Each selected
topic will be fully integrated into your web page providing your audience with
the day's top stories in headline and brief format. A viewer can get a quick
overview using the headlines and briefs, or can delve deeper by clicking on the
headline to access the underlying full-text article.

Each day, by 8:00 AM EST, your site is stocked with fresh content from over 250
worldwide information sources. NewsEdge brings you the hottest, most important
industry news, logically organized for quick and easy use. We spend each night
reviewing over 20,000 news articles. Through the use of technology and human
expertise, we carefully review and evaluate the news to deliver only the news
that is relevant to the interests of your audience.

<PAGE>

                                                                          [LOGO]

PRICING STRUCTURE
The price of the eTopics-TM-` is based on the number of industry-specific topics
that are integrated into your web site. The annual price includes full
implementation of the service and provides full access to all the news for your
audience.

<TABLE>
<CAPTION>
         Item              # ordered                 Price
         ----              ---------                 -----
         <S>               <C>                       <C>
         eTopics-TM-       15                        $15,000*
</TABLE>

* ONE-TIME SETUP FEE OF $1000 IS INCLUDED.

ETOPICS-TM-  BENEFITS
-    Fresh, relevant industry news that is focused on the interests of your
     visitors.

-    Headlines and briefs of the day's top stories with complete
     access to all the articles in full text.

-    Aggregation of news from 250 premium news sources.

-    News is automatically updated on your web site by 8:00 AM EST.

-    Choose from over 1,300 industry-specific topics, enabling you to focus the
     news on highly granular subjects that specifically relate to your audience.

-    Seamless integration of news on your web site. We will maintain your look
     and feel, while enhancing the content offered.

-    Adds stickiness to your site and enables you to draw end users of specific
     communities to view the latest information about their specific interests.

<PAGE>

ACCEPTANCE:
Your signature on this letter will confirm thehealthchannel.com's subscription
to the NewsEdge eTopics-TM- service. Please sign and date a copy of this
agreement and return it to me as approval of the terms and conditions outlined
above.

---------------------
Signature

---------------------
Name/Title

---------------------
Date

Regards,

Bradford Yeager
Regional Manager
eMedia Services
415.836.0673 - W
415.269.0912 - C
415.836.0670 - F

                          bradford.yeager@newsedge.com<PAGE>

                                  EXHIBIT 10.21

                           SWARTZ PRIVATE EQUITY, LLC

                                WARRANT AGREEMENT

                              Dated: June 19, 2000

<PAGE>

THIS WARRANT AND THE SECURITIES ISSUABLE UPON EXERCISE HEREOF HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"),
OR ANY STATE SECURITIES LAW, AND MAY NOT BE SOLD, TRANSFERRED, PLEDGED,
HYPOTHECATED OR OTHERWISE DISPOSED OF OR EXERCISED UNLESS (i) A REGISTRATION
STATEMENT UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS SHALL
HAVE BECOME EFFECTIVE WITH REGARD THERETO, OR (ii) AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS IS
AVAILABLE IN CONNECTION WITH SUCH OFFER, SALE OR TRANSFER.

AN INVESTMENT IN THESE SECURITIES INVOLVES A HIGH DEGREE OF RISK. HOLDERS MUST
RELY ON THEIR OWN ANALYSIS OF THE INVESTMENT AND ASSESSMENT OF THE RISKS
INVOLVED.

Warrant to Purchase
3,450,000 shares

                        WARRANT TO PURCHASE COMMON STOCK
                                       OF
                              THEHEALTHCHANNEL.COM

         THIS CERTIFIES that SWARTZ PRIVATE EQUITY, LLC or any subsequent holder
hereof pursuant to Section 8 hereof ("Holder"), has the right to purchase from
THEHEALTHCHANNEL.COM, a Delaware corporation (the "Company"), up to 3,450,000
fully paid and nonassessable shares of the Company's common stock, $0.00035 par
value per share ("Common Stock"), subject to adjustment as provided herein, at a
price equal to the Exercise Price as defined in Section 3 below, at any time
beginning on the Date of Issuance (defined below) and ending at 5:00 p.m., New
York, New York time the date that is five (5) years after the Date of Issuance
(the "Exercise Period").

         Holder agrees with the Company that this Warrant to Purchase Common
Stock of the Company (this "Warrant") is issued and all rights hereunder shall
be held subject to all of the conditions, limitations and provisions set forth
herein.

         1.       DATE OF ISSUANCE AND TERM.

         This Warrant shall be deemed to be issued on June 19, 2000 ("Date of
Issuance"). The term of this Warrant is five (5) years from the Date of
Issuance.

<PAGE>

         Of this Warrant to purchase three million four hundred-fifty thousand
(3,450,000) shares of Common Stock of the Company, the Warrant is exercisable as
to one million one hundred-fifty thousand (1,150,000) shares of Common Stock of
the Company after the fifteen (15) business day document review period (the
"Review Period") referenced in the Equity Line Letter of Agreement dated on or
about June 19, 2000, between Swartz Private Equity, LLC and Company (the "Letter
of Agreement") has ended, shall be further exercisable as to the an additional
one million one hundred-fifty thousand (1,150,000) shares of Common Stock of the
Company upon the execution by the Company and Swartz Private Equity, LLC of an
Investment Agreement, pursuant to the Letter of Agreement ("Investment
Agreement") and shall be further exercisable as to the remaining one million one
hundred-fifty thousand (1,150,000) shares of Common Stock of the Company upon
the earlier of (i) the date of effectiveness of Company's registration statement
(the "Registration Statement") to be filed pursuant to the Investment Agreement
and related documents, or (ii) December 19, 2000.

         Anything in this Warrant to the contrary notwithstanding, if the
Company delivers written notice to Swartz Private Equity, LLC prior to the
expiration of the Review Period that the legal documents for the transaction are
unacceptable and the Company wishes to terminate the transaction (a "Company
Termination Notice"), Holder shall return this Warrant to the Company and all of
Holder's rights under this Warrant shall be null and void and of no effect,
provided that, if the Company has not delivered a Company Termination Notice to
Swartz Private Equity, LLC, prior to the expiration of the Review Period,
ownership of this Warrant shall irrevocably vest to the Holder, regardless of
whether a Company Termination Notice is delivered anytime thereafter.

         Notwithstanding anything to the contrary herein, the Holder shall not
exercise this warrant if and to the extent that the number of shares of Common
Stock to be issued to Holder upon such exercise, when added to the number of
shares of Common Stock, if any, that the Holder otherwise beneficially owns at
the time of such exercise, would equal or exceed 4.99% of the number of shares
of Common Stock then outstanding, as determined in accordance with Section 13(d)
of the Exchange Act (the "4.99% Limitation"). The 4.99% Limitation shall be
conclusively satisfied if the applicable Exercise Notice includes a signed
representation by the Holder that the issuance of the shares in such Exercise
Notice will not violate the 4.99% Limitation, and the Company shall not be
entitled to require additional documentation of such satisfaction.

         2.       EXERCISE.

         (a)      MANNER OF EXERCISE. During the Exercise Period, this Warrant
may be exercised as to all or any lesser number of full shares of Common Stock
covered hereby (the "Warrant Shares") upon surrender of this Warrant, with the
Exercise Form attached hereto as EXHIBIT A (the "Exercise Form") duly completed
and executed, together with the full Exercise Price (as defined below) for each
share of Common Stock as to which this Warrant is exercised, at the office of
the Company, Attention: Donald Shea, CEO, Attn: Tom Lonergan,
Thehealthchannel.com, 260 Newport Center Drive, Suite 250, Newport Beach, CA
92660; Telephone: (949) 631-8317, Facsimile: (949) 719-6055,or at such other
office or agency as the Company may designate in

<PAGE>

writing, by overnight mail, with an advance copy of the Exercise Form sent to
the Company and its Transfer Agent by facsimile (such surrender and payment
of the Exercise Price hereinafter called the "Exercise of this Warrant").

         (b)      DATE OF EXERCISE. The "Date of Exercise" of the Warrant shall
be defined as the date that the advance copy of the completed and executed
Exercise Form is sent by facsimile to the Company, provided that the original
Warrant and Exercise Form are received by the Company as soon as practicable
thereafter. Alternatively, the Date of Exercise shall be defined as the date the
original Exercise Form is received by the Company, if Holder has not sent
advance notice by facsimile.

         (c)      DELIVERY OF SHARES OF COMMON STOCK UPON EXERCISE. Upon any
exercise of this Warrant, the Company shall deliver, or shall cause its transfer
agent to deliver, a stock certificate or certificates representing the number of
shares of Common Stock into which this Warrant was exercised, within three (3)
trading days of the Date of Exercise (as defined above). Such stock certificates
shall not contain a legend restricting transfer if a registration statement
covering the resale of such shares of Common Stock is in effect at the time of
such exercise or if such shares of Common Stock may be resold pursuant to an
exemption from registration, including but not limited to Rule 144 under the
Securities Act of 1933. If the Company has not delivered stock certificates
representing the requisite number of shares of Common Stock (unlegended, if so
required per the above) within three (3) trading days of the Date of Exercise,
the Company shall pay to the Holder liquidated damages equal to $1,000 per day
until such share certificates (unlegended, if so required per the above) are
received by the Holder.

         (d)      CANCELLATION OF WARRANT. This Warrant shall be canceled upon
the Exercise of this Warrant, and, as soon as practical after the Date of
Exercise, Holder shall be entitled to receive Common Stock for the number of
shares purchased upon such Exercise of this Warrant, and if this Warrant is not
exercised in full, Holder shall be entitled to receive a new Warrant (containing
terms identical to this Warrant) representing any unexercised portion of this
Warrant in addition to such Common Stock.

         (e)      HOLDER OF RECORD. Each person in whose name any Warrant for
shares of Common Stock is issued shall, for all purposes, be deemed to be the
Holder of record of such shares on the Date of Exercise of this Warrant,
irrespective of the date of delivery of the Common Stock purchased upon the
Exercise of this Warrant. Nothing in this Warrant shall be construed as
conferring upon Holder any rights as a stockholder of the Company.

         3.       PAYMENT OF WARRANT EXERCISE PRICE.

         The Exercise Price per share ("Exercise Price") shall initially equal
(the "Initial Exercise Price") the lowest Closing Price for the five (5) trading
days immediately preceding June 19, 2000, which is $0.20. If the lowest Closing
Price of the Company's Common Stock for the five (5) trading days immediately
preceding the date, if any, that Swartz Private Equity, LLC executes an
Investment Agreement pursuant to the Letter of Agreement (the "Closing Market
Price") is less than the Initial Exercise Price, the Exercise Price shall be
reset to equal the Closing Market Price, or, if the Date of Exercise is more
than six (6) months after the Date of

<PAGE>

Issuance, the Exercise Price shall be reset to equal the lesser of (i) the
Exercise Price then in effect, or (ii) the "Lowest Reset Price," as that term
is defined below. The Company shall calculate a "Reset Price" on each
six-month anniversary date of the Date of Issuance which shall equal one
hundred percent (100%) of the lowest Closing Price of the Company's Common
Stock for the five (5) trading days ending on such six-month anniversary date
of the Date of Issuance. The "Lowest Reset Price" shall equal the lowest
Reset Price determined on any six-month anniversary date of the Date of
Issuance preceding the Date of Exercise, taking into account, as appropriate,
any adjustments made pursuant to Section 5 hereof.

         For purposes hereof, the term "Closing Price" shall mean the closing
price on the Nasdaq Small Cap Market, the National Market System ("NMS"), the
New York Stock Exchange, or the O.T.C. Bulletin Board, or if no longer traded on
the Nasdaq Small Cap Market, the National Market System ("NMS"), the New York
Stock Exchange, or the O.T.C. Bulletin Board, the "Closing Price" shall equal
the closing price on the principal national securities exchange or the
over-the-counter system on which the Common Stock is so traded and, if not
available, the mean of the high and low prices on the principal national
securities exchange on which the Common Stock is so traded.

         Payment of the Exercise Price may be made by either of the following,
or a combination thereof, at the election of Holder:

         (i)      CASH EXERCISE: cash, bank or cashiers check or wire transfer;
or

         (ii)     CASHLESS EXERCISE: The Holder, at its option, may exercise
this Warrant in a cashless exercise transaction. In order to effect a Cashless
Exercise, the Holder shall surrender this Warrant at the principal office of the
Company together with notice of cashless election, in which event the Company
shall issue Holder a number of shares of Common Stock computed using the
following formula:

                                  X = Y (A-B)/A

where:   X = the number of shares of Common Stock to be issued to Holder.

         Y = the number of shares of Common Stock for which this Warrant is
being exercised.

                  A = the Market Price of one (1) share of Common Stock (for
                  purposes of this Section 3(ii), the "Market Price" shall be
                  defined as the average Closing Price of the Common Stock for
                  the five (5) trading days prior to the Date of Exercise of
                  this Warrant (the "Average Closing Price"), as reported by the
                  O.T.C. Bulletin Board, National Association of Securities
                  Dealers Automated Quotation System ("Nasdaq") Small Cap
                  Market, or if the Common Stock is not traded on the Nasdaq
                  Small Cap Market, the Average Closing Price in any other
                  over-the-counter market; provided, however, that if the Common
                  Stock is listed on a stock exchange, the Market Price shall be
                  the Average Closing Price on such exchange for the five (5)
                  trading days prior to the date of exercise of the Warrants. If
                  the

<PAGE>

                  Common Stock is/was not traded during the five (5) trading
                  days prior to the Date of Exercise, then the closing price for
                  the last publicly traded day shall be deemed to be the closing
                  price for any and all (if applicable) days during such five
                  (5) trading day period.

                  B = the Exercise Price.

         For purposes of Rule 144 and sub-section (d)(3)(ii) thereof, it is
intended, understood and acknowledged that the Common Stock issuable upon
exercise of this Warrant in a cashless exercise transaction shall be deemed to
have been acquired at the time this Warrant was issued. Moreover, it is
intended, understood and acknowledged that the holding period for the Common
Stock issuable upon exercise of this Warrant in a cashless exercise transaction
shall be deemed to have commenced on the date this Warrant was issued.

         4.       TRANSFER AND REGISTRATION.

         (a)      TRANSFER RIGHTS. Subject to the provisions of Section 8 of
this Warrant, this Warrant may be transferred on the books of the Company, in
whole or in part, in person or by attorney, upon surrender of this Warrant
properly completed and endorsed. This Warrant shall be canceled upon such
surrender and, as soon as practicable thereafter, the person to whom such
transfer is made shall be entitled to receive a new Warrant or Warrants as to
the portion of this Warrant transferred, and Holder shall be entitled to receive
a new Warrant as to the portion hereof retained.

         (b)      REGISTRABLE SECURITIES. In addition to any other registration
rights of the Holder, if the Common Stock issuable upon exercise of this Warrant
is not registered for resale at the time the Company proposes to register
(including for this purpose a registration effected by the Company for
stockholders other than the Holders) any of its Common Stock under the Act
(other than a registration relating solely for the sale of securities to
participants in a Company stock plan or a registration on Form S-4 promulgated
under the Act or any successor or similar form registering stock issuable upon a
reclassification, upon a business combination involving an exchange of
securities or upon an exchange offer for securities of the issuer or another
entity)(a "Piggyback Registration Statement"), the Company shall cause to be
included in such Piggyback Registration Statement ("Piggyback Registration") all
of the Common Stock issuable upon the exercise of this Warrant ("Registrable
Securities") to the extent such inclusion does not violate the registration
rights of any other securityholder of the Company granted prior to the date
hereof. Nothing herein shall prevent the Company from withdrawing or abandoning
the Piggyback Registration Statement prior to its effectiveness.

         (c)      LIMITATION ON OBLIGATIONS TO REGISTER UNDER A PIGGYBACK
REGISTRATION. In the case of a Piggyback Registration pursuant to an
underwritten public offering by the Company, if the managing underwriter
determines and advises in writing that the inclusion in the registration
statement of all Registrable Securities proposed to be included would interfere
with the successful marketing of the securities proposed to be registered by the
Company, then the

<PAGE>

number of such Registrable Securities to be included in the Piggyback
Registration Statement, to the extent such Registrable Securities may be
included in such Piggyback Registration Statement, shall be allocated among
all Holders who had requested Piggyback Registration pursuant to the terms
hereof, in the proportion that the number of Registrable Securities which
each such Holder seeks to register bears to the total number of Registrable
Securities sought to be included by all Holders. If required by the managing
underwriter of such an underwritten public offering, the Holders shall enter
into a reasonable agreement limiting the number of Registrable Securities to
be included in such Piggyback Registration Statement and the terms, if any,
regarding the future sale of such Registrable Securities.

         5.       ANTI-DILUTION ADJUSTMENTS.

         (a)      STOCK DIVIDEND. If the Company shall at any time declare a
dividend payable in shares of Common Stock, then Holder, upon Exercise of this
Warrant after the record date for the determination of holders of Common Stock
entitled to receive such dividend, shall be entitled to receive upon Exercise of
this Warrant, in addition to the number of shares of Common Stock as to which
this Warrant is exercised, such additional shares of Common Stock as such Holder
would have received had this Warrant been exercised immediately prior to such
record date and the Exercise Price will be proportionately adjusted.

         (b)      RECAPITALIZATION OR RECLASSIFICATION.

                  (i)      STOCK SPLIT. If the Company shall at any time effect
a recapitalization, reclassification or other similar transaction of such
character that the shares of Common Stock shall be changed into or become
exchangeable for a LARGER number of shares (a "Stock Split"), then upon the
effective date thereof, the number of shares of Common Stock which Holder shall
be entitled to purchase upon Exercise of this Warrant shall be increased in
direct proportion to the increase in the number of shares of Common Stock by
reason of such recapitalization, reclassification or similar transaction, and
the Exercise Price shall be proportionally decreased.

                  (ii)     REVERSE STOCK SPLIT. If the Company shall at any time
effect a recapitalization, reclassification or other similar transaction of such
character that the shares of Common Stock shall be changed into or become
exchangeable for a SMALLER number of shares (a "Reverse Stock Split"), then upon
the effective date thereof, the number of shares of Common Stock which Holder
shall be entitled to purchase upon Exercise of this Warrant shall be
proportionately decreased and the Exercise Price shall be proportionally
increased. The Company shall give Holder the same notice it provides to holders
of Common Stock of any transaction described in this Section 5(b).

         (c)      DISTRIBUTIONS. If the Company shall at any time distribute for
no consideration to holders of Common Stock cash, evidences of indebtedness or
other securities or assets (other than cash dividends or distributions payable
out of earned surplus or net profits for the current or preceding years) then,
in any such case, Holder shall be entitled to receive, upon Exercise of this
Warrant, with respect to each share of Common Stock issuable upon such exercise,
the amount of cash or evidences of indebtedness or other securities or assets
which Holder would have been entitled to receive with respect to each such share
of Common Stock as a result of the happening

<PAGE>

of such event had this Warrant been exercised immediately prior to the record
date or other date fixing shareholders to be affected by such event (the
"Determination Date") or, in lieu thereof, if the Board of Directors of the
Company should so determine at the time of such distribution, a reduced
Exercise Price determined by multiplying the Exercise Price on the
Determination Date by a fraction, the numerator of which is the result of
such Exercise Price reduced by the value of such distribution applicable to
one share of Common Stock (such value to be determined by the Board of
Directors of the Company in its discretion) and the denominator of which is
such Exercise Price.

         (d)      NOTICE OF CONSOLIDATION OR MERGER. In the event of a merger,
consolidation, exchange of shares, recapitalization, reorganization, or other
similar event, as a result of which shares of Common Stock shall be changed into
the same or a different number of shares of the same or another class or classes
of stock or securities or other assets of the Company or another entity or there
is a sale of all or substantially all the Company's assets (a "Corporate
Change"), then this Warrant shall be exerciseable into such class and type of
securities or other assets as Holder would have received had Holder exercised
this Warrant immediately prior to such Corporate Change; provided, however, that
Company may not affect any Corporate Change unless it first shall have given
thirty (30) days notice to Holder hereof of any Corporate Change.

         (e)      EXERCISE PRICE ADJUSTED. As used in this Warrant, the term
"Exercise Price" shall mean the purchase price per share specified in Section 3
of this Warrant, until the occurrence of an event stated in subsection (a), (b)
or (c) of this Section 5, and thereafter shall mean said price as adjusted from
time to time in accordance with the provisions of said subsection. No such
adjustment under this Section 5 shall be made unless such adjustment would
change the Exercise Price at the time by $.01 or more; provided, however, that
all adjustments not so made shall be deferred and made when the aggregate
thereof would change the Exercise Price at the time by $.01 or more.

         (f)      ADJUSTMENTS: ADDITIONAL SHARES, SECURITIES OR ASSETS. In the
event that at any time, as a result of an adjustment made pursuant to this
Section 5, Holder shall, upon Exercise of this Warrant, become entitled to
receive shares and/or other securities or assets (other than Common Stock) then,
wherever appropriate, all references herein to shares of Common Stock shall be
deemed to refer to and include such shares and/or other securities or assets;
and thereafter the number of such shares and/or other securities or assets shall
be subject to adjustment from time to time in a manner and upon terms as nearly
equivalent as practicable to the provisions of this Section 5.

         6.       FRACTIONAL INTERESTS.

                  No fractional shares or scrip representing fractional shares
shall be issuable upon the Exercise of this Warrant, but on Exercise of this
Warrant, Holder may purchase only a whole number of shares of Common Stock. If,
on Exercise of this Warrant, Holder would be entitled to a fractional share of
Common Stock or a right to acquire a fractional share of Common Stock, such
fractional share shall be disregarded and the number of shares of Common Stock
issuable upon exercise shall be the next higher number of shares.

<PAGE>

7.       RESERVATION OF SHARES.

                  The Company shall at all times reserve for issuance such
number of authorized and unissued shares of Common Stock (or other securities
substituted therefor as herein above provided) as shall be sufficient for the
Exercise of this Warrant and payment of the Exercise Price. The Company
covenants and agrees that upon the Exercise of this Warrant, all shares of
Common Stock issuable upon such exercise shall be duly and validly issued, fully
paid, nonassessable and not subject to preemptive rights, rights of first
refusal or similar rights of any person or entity.

8.       RESTRICTIONS ON TRANSFER.

                  (a)      REGISTRATION OR EXEMPTION REQUIRED. This Warrant has
been issued in a transaction exempt from the registration requirements of the
Act by virtue of Regulation D and exempt from state registration under
applicable state laws. The Warrant and the Common Stock issuable upon the
Exercise of this Warrant may not be pledged, transferred, sold or assigned
except pursuant to an effective registration statement or unless the Company has
received an opinion from the Company's counsel to the effect that such
registration is not required, or the Holder has furnished to the Company an
opinion of the Holder's counsel, which counsel shall be reasonably satisfactory
to the Company, to the effect that such registration is not required; the
transfer complies with any applicable state securities laws; and, if no
registration covering the resale of the Warrant Shares is effective at the time
the Warrant Shares are issued, the Holder consents to a legend being placed on
certificates for the Warrant Shares stating that the securities have not been
registered under the Securities Act and referring to such restrictions on
transferability and sale.

                  (b)      ASSIGNMENT. If Holder can provide the Company with
reasonably satisfactory evidence that the conditions of (a) above regarding
registration or exemption have been satisfied, Holder may sell, transfer,
assign, pledge or otherwise dispose of this Warrant, in whole or in part. Holder
shall deliver a written notice to Company, substantially in the form of the
Assignment attached hereto as EXHIBIT B, indicating the person or persons to
whom the Warrant shall be assigned and the respective number of warrants to be
assigned to each assignee. The Company shall effect the assignment within ten
(10) days, and shall deliver to the assignee(s) designated by Holder a Warrant
or Warrants of like tenor and terms for the appropriate number of shares.

         9.       BENEFITS OF THIS WARRANT.

                  Nothing in this Warrant shall be construed to confer upon any
person other than the Company and Holder any legal or equitable right, remedy or
claim under this Warrant and this Warrant shall be for the sole and exclusive
benefit of the Company and Holder.

<PAGE>

         10.      APPLICABLE LAW.

                  This Warrant is issued under and shall for all purposes be
governed by and construed in accordance with the laws of the state of Delaware,
without giving effect to conflict of law provisions thereof.

         11.      LOSS OF WARRANT.

                  Upon receipt by the Company of evidence of the loss, theft,
destruction or mutilation of this Warrant, and (in the case of loss, theft or
destruction) of indemnity or security reasonably satisfactory to the Company,
and upon surrender and cancellation of this Warrant, if mutilated, the Company
shall execute and deliver a new Warrant of like tenor and date.

         12.      NOTICE OR DEMANDS.

Notices or demands pursuant to this Warrant to be given or made by Holder to or
on the Company shall be sufficiently given or made if sent by certified or
registered mail, return receipt requested, postage prepaid, and addressed, until
another address is designated in writing by the Company, to the address set
forth in Section 2(a) above. Notices or demands pursuant to this Warrant to be
given or made by the Company to or on Holder shall be sufficiently given or made
if sent by certified or registered mail, return receipt requested, postage
prepaid, and addressed, to the address of Holder set forth in the Company's
records, until another address is designated in writing by Holder.

         IN WITNESS WHEREOF, the undersigned has executed this Warrant as of the
____ day of June, 2000.

                                            THEHEALTHCHANNEL.COM

                                            By:
                                               --------------------------------
                                              Donald Shea, CEO

<PAGE>

                                    EXHIBIT A

                            EXERCISE FORM FOR WARRANT

                            TO: THEHEALTHCHANNEL.COM

         The undersigned hereby irrevocably exercises the right to purchase
____________ of the shares of Common Stock (the "Common Stock") of
THEHEALTHCHANNEL.COM a Delaware corporation (the "Company"), evidenced by the
attached warrant (the "Warrant"), and herewith makes payment of the exercise
price with respect to such shares in full, all in accordance with the conditions
and provisions of said Warrant.

1. The undersigned agrees not to offer, sell, transfer or otherwise dispose of
any of the Common Stock obtained on exercise of the Warrant, except in
accordance with the provisions of Section 8(a) of the Warrant.

2. The undersigned requests that stock certificates for such shares be issued
free of any restrictive legend, if appropriate, and a warrant representing any
unexercised portion hereof be issued, pursuant to the Warrant in the name of the
undersigned and delivered to the undersigned at the address set forth below:

Dated:
       ------------------

------------------------------------------------------------------------
                                    Signature

-----------------------------------------------------------------------
                                   Print Name

------------------------------------------------------------------------
                                     Address

-----------------------------------------------------------------------

NOTICE

The signature to the foregoing Exercise Form must correspond to the name as
written upon the face of the attached Warrant in every particular, without
alteration or enlargement or any change whatsoever.

------------------------------------------------------------------------

<PAGE>

                                    EXHIBIT B

                                   ASSIGNMENT

                    (To be executed by the registered holder
                        desiring to transfer the Warrant)

FOR VALUE RECEIVED, the undersigned holder of the attached warrant (the
"Warrant") hereby sells, assigns and transfers unto the person or persons below
named the right to purchase _______ shares of the Common Stock of
THEHEALTHCHANNEL.COM, evidenced by the attached Warrant and does hereby
irrevocably constitute and appoint _______________________ attorney to transfer
the said Warrant on the books of the Company, with full power of substitution in
the premises.

Dated:
                                    -----------------------------------------
                                    Signature

Fill in for new registration of Warrant:

-----------------------------------
                  Name

-----------------------------------
                  Address

-----------------------------------
Please print name and address of assignee
(including zip code number)

-----------------------------------------------------------------------

NOTICE

The signature to the foregoing Assignment must correspond to the name as written
upon the face of the attached Warrant in every particular, without alteration or
enlargement or any change whatsoever.

------------------------------------------------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00014-of-00352.parquet"}]]